Published in

De Gruyter, Clinical Chemistry and Laboratory Medicine, 1(53), 2015

DOI: 10.1515/cclm-2014-0647

Links

Tools

Export citation

Search in Google Scholar

Urinary neutrophil gelatinase-associated lipocalin and clinical outcomes in chronic kidney disease patients

This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Red circle
Preprint: archiving forbidden
Red circle
Postprint: archiving forbidden
Orange circle
Published version: archiving restricted
Data provided by SHERPA/RoMEO

Abstract

AbstractTubulointerstitial damage is a final common pathway of most renal diseases. Whether urinary neutrophil gelatinase-associated lipocalin (uNGAL), a biomarker for renal tubular damage, is of prognostic value for clinical outcomes in chronic kidney disease (CKD) patients has not been well investigated.The uNGAL and proteinuria levels were measured among a cohort of 473 advanced CKD patients of various etiologies recruited during 2002–2009.The estimated glomerular filtration rate (eGFR) was 32.3±22.0 mL/min/1.73 mElevated uNGAL in CKD patients is associated with risks for ESRD and probably CV events. UNPR could improve the prediction for ESRD.